# Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center retrospective study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-cetuximab-containing-chemotherapy-after-immune-checkpoint/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Takashi Kurosaki,Seiichiro Mitani,Kaoru Tanaka,Shinichiro Suzuki,Hiroaki Kanemura,Koji Haratani,Soichi Fumita,Tsutomu Iwasa,Hidetoshi Hayashi,Takeshi Yoshida,Kazuki Ishikawa,Mutsukazu Kitano,Naoki Otsuki,Yasumasa Nishimura,Katsumi Doi,Kazuhiko Nakagawa |
| Citations | 27 |
| DOI | 10.1097/cad.0000000000001006 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1097/cad.0000000000001006 |
| OpenAlex ID | https://openalex.org/W3088991262 |
| PMID | 32976215 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Soichi Fumita](https://scholariq.org/researchers/soichi-fumita/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.